This site is intended for healthcare professionals
Drug news

Zytiga (abiraterone) in combination with prednisone and ADT filed with FDA for supplemental New Drug Application in metastatic hormone na�ve prostate cancer or newly diagnosed, high-risk metastatic hormone sensitive prostate cancer.- Janssen Biotech.

Read time: 1 mins
Last updated:15th Sep 2017
Published:15th Sep 2017
Source: Pharmawand
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest